Compile Data Set for Download or QSAR
Report error Found 131 Enz. Inhib. hit(s) with all data for entry = 1150
TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212499(US9278944, 57 | US10155731, Example 57)
Affinity DataIC50: 0.400nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212579(US9278944, 270 | US10155731, Example 270)
Affinity DataIC50: 0.400nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212482(US9278944, 36 | US10155731, Example 36)
Affinity DataIC50: 0.5nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212584(US9278944, 284 | US10155731, Example 284)
Affinity DataIC50: 0.5nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212512(US9278944, 70 | US10155731, Example 70)
Affinity DataIC50: 0.600nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212532(US9278944, 97 | US10155731, Example 97)
Affinity DataIC50: 0.700nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212506(US9278944, 64 | US10155731, Example 64)
Affinity DataIC50: 0.900nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212582(US9278944, 280 | US10155731, Example 280)
Affinity DataIC50: 0.900nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212516(US9278944, 78 | US10155731, Example 78)
Affinity DataIC50: 1nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212517(US9278944, 79 | US10155731, Example 79)
Affinity DataIC50: 1.10nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212466(US9278944, 10 | US10155731, Example 10)
Affinity DataIC50: 1.20nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212575(US9278944, 152 | US10155731, Example 152)
Affinity DataIC50: 1.20nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM311173(US10155731, Example 304)
Affinity DataIC50: 1.30nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212477(US9278944, 28 | US10155731, Example 28)
Affinity DataIC50: 1.40nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212485(US9278944, 39 | US10155731, Example 39)
Affinity DataIC50: 1.40nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212488(US9278944, 42 | US10155731, Example 42)
Affinity DataIC50: 1.5nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212509(US9278944, 67 | US10155731, Example 67)
Affinity DataIC50: 1.5nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212489(US9278944, 43 | US10155731, Example 43)
Affinity DataIC50: 1.60nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM311171(US10155731, Example 299)
Affinity DataIC50: 1.60nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212497(US9278944, 55 | US10155731, Example 55)
Affinity DataIC50: 1.90nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212501(US9278944, 59 | US10155731, Example 59)
Affinity DataIC50: 2.10nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212487(US9278944, 41 | US10155731, Example 41)
Affinity DataIC50: 2.30nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212508(US9278944, 66 | US10155731, Example 66)
Affinity DataIC50: 2.40nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212538(US9278944, 103 | US10155731, Example 103)
Affinity DataIC50: 2.40nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212563(US9278944, 276 | US9278944, 139 | US10155731, Exam...)
Affinity DataIC50: 2.5nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212563(US9278944, 276 | US9278944, 139 | US10155731, Exam...)
Affinity DataIC50: 2.5nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212586(US9278944, 286 | US10155731, Example 286)
Affinity DataIC50: 3nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212550(US9278944, 124 | US10155731, Example 124)
Affinity DataIC50: 3.20nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212554(US9278944, 128 | US10155731, Example 128)
Affinity DataIC50: 3.30nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM311172(US10155731, Example 301)
Affinity DataIC50: 3.30nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212577(US9278944, 268 | US10155731, Example 268)
Affinity DataIC50: 3.60nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212484(US9278944, 38 | US10155731, Example 38)
Affinity DataIC50: 3.70nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212580(US9278944, 271 | US10155731, Example 271)
Affinity DataIC50: 3.70nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212526(US9278944, 89 | US10155731, Example 89)
Affinity DataIC50: 3.90nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212565(US9278944, 141 | US10155731, Example 141)
Affinity DataIC50: 4nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212545(US9278944, 114 | US10155731, Example 114)
Affinity DataIC50: 4.10nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212494(US9278944, 52 | US10155731, Example 52)
Affinity DataIC50: 4.20nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212533(US9278944, 98 | US10155731, Example 98)
Affinity DataIC50: 4.40nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212568(US9278944, 144 | US10155731, Example 144)
Affinity DataIC50: 4.80nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212478(US9278944, 29 | US10155731, Example 29)
Affinity DataIC50: 5.90nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212585(US9278944, 285 | US10155731, Example 285)
Affinity DataIC50: 6.10nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212561(US9278944, 137 | US10155731, Example 137)
Affinity DataIC50: 6.30nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212507(US9278944, 65 | US10155731, Example 65)
Affinity DataIC50: 6.40nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212483(US9278944, 37 | US10155731, Example 37)
Affinity DataIC50: 6.60nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212552(US9278944, 126 | US10155731, Example 126)
Affinity DataIC50: 6.60nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212578(US9278944, 269 | US10155731, Example 269)
Affinity DataIC50: 6.60nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212583(US9278944, 281 | US10155731, Example 281)
Affinity DataIC50: 6.70nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212481(US9278944, 35 | US10155731, Example 35)
Affinity DataIC50: 6.80nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212502(US9278944, 60 | US10155731, Example 60)
Affinity DataIC50: 7nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM212524(US9278944, 87 | US10155731, Example 87)
Affinity DataIC50: 7nMAssay Description:A substrate of synthetic peptide (Nma-KHPFH LVIHK(Dnp)-NH2) and test compound were mixed, and fluorescence intensity was assayed using a fluorophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 131 total ) | Next | Last >>
Jump to: